 | • レポートコード：QFJ1-5490 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、120ページ • 納品方法：Eメール（納期：3日） • 産業分類：新技術 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、NGSベース監視＆診断検査の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（商業的分析/試験、実験室開発試験、直接消費者試験、商業前試験）、用途別市場規模（外来クリニック/一般開業医、診断センター、病院、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・NGSベース監視＆診断検査の市場動向 ・企業の競争状況、市場シェア ・NGSベース監視＆診断検査の種類別市場規模と予測2016-2027（商業的分析/試験、実験室開発試験、直接消費者試験、商業前試験） ・NGSベース監視＆診断検査の用途別市場規模と予測2016-2027（外来クリニック/一般開業医、診断センター、病院、その他） ・NGSベース監視＆診断検査の北米市場規模2016-2027（アメリカ、カナダ） ・NGSベース監視＆診断検査の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・NGSベース監視＆診断検査のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・NGSベース監視＆診断検査の中南米市場規模2016-2027（メキシコ、ブラジル） ・NGSベース監視＆診断検査の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Agilent Technologies, Inc.、Ancestry.com LLC、ArcherDX, Inc.、Beijing Genomics Institute (BGI)、Cancer Genetics, Inc.、CENTOGENE AG、F. Hoffmann-La Roche Ltd、GenePath Dx、Illumina, Inc.、Laboratory Corporation of America Holdings、Myriad Genetics, Inc.、QIAGEN N.V.、Quest Diagnostics Incorporated、Siemens Healthineers, Inc.、Thermo Fisher Scientific Inc.、HTG Molecular Diagnostics, Inc.、Vela Diagnostics Pte. Ltd.） ・結論 |
NGS-Based Monitoring and Diagnostic Test is based on the NGS, aiming for the monitoring and diagnostic test. Next generation sequencing (NGS), massively parallel or deep sequencing are related terms that describe a DNA sequencing technology which has revolutionised genomic research. Using NGS an entire human genome can be sequenced within a single day.
In 2021, the global NGS-Based Monitoring and Diagnostic Test market size will be US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX% during 2021-2027.
This report focuses on the global NGS-Based Monitoring and Diagnostic Test status, future forecast, growth opportunity, key market, and key players. The study objectives are to present the NGS-Based Monitoring and Diagnostic Test development in North America, Europe, Japan, China, Southeast Asia, India, etc.
Global NGS-Based Monitoring and Diagnostic Test Scope and Market Size
NGS-Based Monitoring and Diagnostic Test market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global NGS-Based Monitoring and Diagnostic Test market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Commercial Assays/Tests
Laboratory Developed Tests
Direct to Consumer Test
Pre-Commercial Tests
Segment by Application
Out-Patient Clinics/General Practitioners
Diagnostic Centers
Hospitals
Others
By Region
North America
Europe
Japan
China
Southeast Asia
India
By Company
Agilent Technologies, Inc.
Ancestry.com LLC
ArcherDX, Inc.
Beijing Genomics Institute (BGI)
Cancer Genetics, Inc.
CENTOGENE AG
F. Hoffmann-La Roche Ltd
GenePath Dx
Illumina, Inc.
Laboratory Corporation of America Holdings
Myriad Genetics, Inc.
QIAGEN N.V.
Quest Diagnostics Incorporated
Siemens Healthineers, Inc.
Thermo Fisher Scientific Inc.
HTG Molecular Diagnostics, Inc.
Vela Diagnostics Pte. Ltd.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global NGS-Based Monitoring and Diagnostic Test Market Size Growth Rate by Type (2021-2027)
1.2.2 Commercial Assays/Tests
1.2.3 Laboratory Developed Tests
1.2.4 Direct to Consumer Test
1.2.5 Pre-Commercial Tests
1.3 Market by Application
1.3.1 Global NGS-Based Monitoring and Diagnostic Test Market Share by Application (2021-2027)
1.3.2 Out-Patient Clinics/General Practitioners
1.3.3 Diagnostic Centers
1.3.4 Hospitals
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global NGS-Based Monitoring and Diagnostic Test Market Size
2.2 NGS-Based Monitoring and Diagnostic Test Market Size by Regions
2.2.1 NGS-Based Monitoring and Diagnostic Test Growth Rate by Regions (2021-2027)
2.2.2 NGS-Based Monitoring and Diagnostic Test Market Share by Regions (2021-2027)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Use Cases
3 Key Players
3.1 NGS-Based Monitoring and Diagnostic Test Revenue by Players (2020-2021)
3.2 NGS-Based Monitoring and Diagnostic Test Key Players Headquaters and Area Served
3.3 Key Players NGS-Based Monitoring and Diagnostic Test Product/Solution/Service
3.4 Date of Enter into NGS-Based Monitoring and Diagnostic Test Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown by Type and by Application
4.1 Global NGS-Based Monitoring and Diagnostic Test Market Size by Type (2021-2027)
4.2 Global NGS-Based Monitoring and Diagnostic Test Market Size by Application (2021-2027)
5 North America
5.1 North America NGS-Based Monitoring and Diagnostic Test Market Forecast (2021-2027)
5.2 NGS-Based Monitoring and Diagnostic Test Key Players in North America
5.3 North America NGS-Based Monitoring and Diagnostic Test Market Size by Type
5.4 North America NGS-Based Monitoring and Diagnostic Test Market Size by Application
6.4.4 Canada
6 Europe
6.1 Europe NGS-Based Monitoring and Diagnostic Test Market Forecast (2021-2027)
6.2 NGS-Based Monitoring and Diagnostic Test Key Players in Europe
6.3 Europe NGS-Based Monitoring and Diagnostic Test Market Size by Type
6.4 Europe NGS-Based Monitoring and Diagnostic Test Market Size by Application
7 Japan
7.1 Japan NGS-Based Monitoring and Diagnostic Test Market Forecast (2021-2027)
7.2 NGS-Based Monitoring and Diagnostic Test Key Players in Europe
7.3 Japan NGS-Based Monitoring and Diagnostic Test Market Size by Type
7.4 Japan NGS-Based Monitoring and Diagnostic Test Market Size by Application
8 Rest of World
8.1 China
8.1.1 China NGS-Based Monitoring and Diagnostic Test Market Analysis
8.1.2 Key Players in China
8.2 Southeast Asia
8.2.1 Southeast Asia NGS-Based Monitoring and Diagnostic Test Market Analysis
8.2.2 Key Players in Southeast Asia
8.3 India
8.3.1 India NGS-Based Monitoring and Diagnostic Test Market Analysis
8.3.2 Key Players in India
9 International Player Profiles
9.1 Agilent Technologies, Inc.
9.1.1 Agilent Technologies, Inc. Company Details
9.1.2 Agilent Technologies, Inc. Description and Business Overview
9.1.3 Agilent Technologies, Inc. NGS-Based Monitoring and Diagnostic Test Introduction
9.1.4 Agilent Technologies, Inc. Revenue in NGS-Based Monitoring and Diagnostic Test Business (2020-2021)
9.1.5 Agilent Technologies, Inc. Recent Development
9.2 Ancestry.com LLC
9.2.1 Ancestry.com LLC Company Details
9.2.2 Ancestry.com LLC Description and Business Overview
9.2.3 Ancestry.com LLC NGS-Based Monitoring and Diagnostic Test Introduction
9.2.4 Ancestry.com LLC Revenue in NGS-Based Monitoring and Diagnostic Test Business (2020-2021)
9.2.5 Ancestry.com LLC Recent Development
9.3 ArcherDX, Inc.
9.3.1 ArcherDX, Inc. Company Details
9.3.2 ArcherDX, Inc. Description and Business Overview
9.3.3 ArcherDX, Inc. NGS-Based Monitoring and Diagnostic Test Introduction
9.3.4 ArcherDX, Inc. Revenue in NGS-Based Monitoring and Diagnostic Test Business (2020-2021)
9.3.5 ArcherDX, Inc. Recent Development
9.4 Beijing Genomics Institute (BGI)
9.4.1 Beijing Genomics Institute (BGI) Company Details
9.4.2 Beijing Genomics Institute (BGI) Description and Business Overview
9.4.3 Beijing Genomics Institute (BGI) NGS-Based Monitoring and Diagnostic Test Introduction
9.4.4 Beijing Genomics Institute (BGI) Revenue in NGS-Based Monitoring and Diagnostic Test Business (2020-2021)
9.4.5 Beijing Genomics Institute (BGI) Recent Development
9.5 Cancer Genetics, Inc.
9.5.1 Cancer Genetics, Inc. Company Details
9.5.2 Cancer Genetics, Inc. Description and Business Overview
9.5.3 Cancer Genetics, Inc. NGS-Based Monitoring and Diagnostic Test Introduction
9.5.4 Cancer Genetics, Inc. Revenue in NGS-Based Monitoring and Diagnostic Test Business (2020-2021)
9.5.5 Cancer Genetics, Inc. Recent Development
9.6 CENTOGENE AG
9.6.1 CENTOGENE AG Company Details
9.6.2 CENTOGENE AG Description and Business Overview
9.6.3 CENTOGENE AG NGS-Based Monitoring and Diagnostic Test Introduction
9.6.4 CENTOGENE AG Revenue in NGS-Based Monitoring and Diagnostic Test Business (2020-2021)
9.6.5 CENTOGENE AG Recent Development
9.7 F. Hoffmann-La Roche Ltd
9.7.1 F. Hoffmann-La Roche Ltd Company Details
9.7.2 F. Hoffmann-La Roche Ltd Description and Business Overview
9.7.3 F. Hoffmann-La Roche Ltd NGS-Based Monitoring and Diagnostic Test Introduction
9.7.4 F. Hoffmann-La Roche Ltd Revenue in NGS-Based Monitoring and Diagnostic Test Business (2020-2021)
9.7.5 F. Hoffmann-La Roche Ltd Recent Development
9.8 GenePath Dx
9.8.1 GenePath Dx Company Details
9.8.2 GenePath Dx Description and Business Overview
9.8.3 GenePath Dx NGS-Based Monitoring and Diagnostic Test Introduction
9.8.4 GenePath Dx Revenue in NGS-Based Monitoring and Diagnostic Test Business (2020-2021)
9.8.5 GenePath Dx Recent Development
9.9 Illumina, Inc.
9.9.1 Illumina, Inc. Company Details
9.9.2 Illumina, Inc. Description and Business Overview
9.9.3 Illumina, Inc. NGS-Based Monitoring and Diagnostic Test Introduction
9.9.4 Illumina, Inc. Revenue in NGS-Based Monitoring and Diagnostic Test Business (2020-2021)
9.9.5 Illumina, Inc. Recent Development
9.10 Laboratory Corporation of America Holdings
9.10.1 Laboratory Corporation of America Holdings Company Details
9.10.2 Laboratory Corporation of America Holdings Description and Business Overview
9.10.3 Laboratory Corporation of America Holdings NGS-Based Monitoring and Diagnostic Test Introduction
9.10.4 Laboratory Corporation of America Holdings Revenue in NGS-Based Monitoring and Diagnostic Test Business (2020-2021)
9.10.5 Laboratory Corporation of America Holdings Recent Development
9.11 Myriad Genetics, Inc.
9.11.1 Myriad Genetics, Inc. Company Details
9.11.2 Myriad Genetics, Inc. Description and Business Overview
9.11.3 Myriad Genetics, Inc. NGS-Based Monitoring and Diagnostic Test Introduction
9.11.4 Myriad Genetics, Inc. Revenue in NGS-Based Monitoring and Diagnostic Test Business (2020-2021)
9.11.5 Myriad Genetics, Inc. Recent Development
9.12 QIAGEN N.V.
9.12.1 QIAGEN N.V. Company Details
9.12.2 QIAGEN N.V. Description and Business Overview
9.12.3 QIAGEN N.V. NGS-Based Monitoring and Diagnostic Test Introduction
9.12.4 QIAGEN N.V. Revenue in NGS-Based Monitoring and Diagnostic Test Business (2020-2021)
9.12.5 QIAGEN N.V. Recent Development
9.13 Quest Diagnostics Incorporated
9.13.1 Quest Diagnostics Incorporated Company Details
9.13.2 Quest Diagnostics Incorporated Description and Business Overview
9.13.3 Quest Diagnostics Incorporated NGS-Based Monitoring and Diagnostic Test Introduction
9.13.4 Quest Diagnostics Incorporated Revenue in NGS-Based Monitoring and Diagnostic Test Business (2020-2021)
9.13.5 Quest Diagnostics Incorporated Recent Development
9.14 Siemens Healthineers, Inc.
9.14.1 Siemens Healthineers, Inc. Company Details
9.14.2 Siemens Healthineers, Inc. Description and Business Overview
9.14.3 Siemens Healthineers, Inc. NGS-Based Monitoring and Diagnostic Test Introduction
9.14.4 Siemens Healthineers, Inc. Revenue in NGS-Based Monitoring and Diagnostic Test Business (2020-2021)
9.14.5 Siemens Healthineers, Inc. Recent Development
9.15 Thermo Fisher Scientific Inc.
9.15.1 Thermo Fisher Scientific Inc. Company Details
9.15.2 Thermo Fisher Scientific Inc. Description and Business Overview
9.15.3 Thermo Fisher Scientific Inc. NGS-Based Monitoring and Diagnostic Test Introduction
9.15.4 Thermo Fisher Scientific Inc. Revenue in NGS-Based Monitoring and Diagnostic Test Business (2020-2021)
9.15.5 Thermo Fisher Scientific Inc. Recent Development
9.16 HTG Molecular Diagnostics, Inc.
9.16.1 Company Details
9.16.2 HTG Molecular Diagnostics, Inc. Description and Business Overview
9.16.3 HTG Molecular Diagnostics, Inc. NGS-Based Monitoring and Diagnostic Test Introduction
9.16.4 HTG Molecular Diagnostics, Inc. Revenue in NGS-Based Monitoring and Diagnostic Test Business (2020-2021)
9.16.5 HTG Molecular Diagnostics, Inc. Recent Development
9.17 Vela Diagnostics Pte. Ltd.
9.17.1 Vela Diagnostics Pte. Ltd. Company Details
9.17.2 Vela Diagnostics Pte. Ltd. Description and Business Overview
9.17.3 Vela Diagnostics Pte. Ltd. NGS-Based Monitoring and Diagnostic Test Introduction
9.17.4 Vela Diagnostics Pte. Ltd. Revenue in NGS-Based Monitoring and Diagnostic Test Business (2020-2021)
9.17.5 Vela Diagnostics Pte. Ltd. Recent Development
10 Market Dynamics
10.1 Industry Trends
10.2 Market Drives
10.3 Market Challenges
10.4 Market Restraints
11 Key Findings in This Report
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.2 Data Source
12.2 Disclaimer
12.3 Author Details
Table 1. Global NGS-Based Monitoring and Diagnostic Test Market Size Growth Rate by Type (2021-2027) (US$ Million)
Table 2. Key Players of Commercial Assays/Tests
Table 3. Key Players of Laboratory Developed Tests
Table 4. Key Players of Direct to Consumer Test
Table 5. Key Players of Pre-Commercial Tests
Table 6. Global NGS-Based Monitoring and Diagnostic Test Market Size Growth by Application (2021-2027) (US$ Million)
Table 7. Global NGS-Based Monitoring and Diagnostic Test Market Size by Regions (2021-2027) (US$ Million)
Table 8. Global NGS-Based Monitoring and Diagnostic Test Market Share by Regions (2021-2027)
Table 9. Market Top Trends
Table 10. Market Use Cases
Table 11. Global NGS-Based Monitoring and Diagnostic Test Revenue by Players (2020-2021) (US$ Million)
Table 12. Global NGS-Based Monitoring and Diagnostic Test Market Share by Players (2020-2021)
Table 13. Key Players Headquarters and Area Served
Table 14. Key Players NGS-Based Monitoring and Diagnostic Test Product Solution and Service
Table 15. Date of Enter into NGS-Based Monitoring and Diagnostic Test Market
Table 16. Mergers & Acquisitions, Expansion Plans
Table 17. Global NGS-Based Monitoring and Diagnostic Test Market Size by Type (2021-2027) (US$ Million)
Table 18. Global NGS-Based Monitoring and Diagnostic Test Market Size Share by Type (2021-2027)
Table 19. Global NGS-Based Monitoring and Diagnostic Test Market Size by Application (2021-2027) (US$ Million)
Table 20. Global NGS-Based Monitoring and Diagnostic Test Market Size Share by Application (2021-2027)
Table 21. North America Key Players NGS-Based Monitoring and Diagnostic Test Revenue (2020-2021) (US$ Million)
Table 22. North America Key Players NGS-Based Monitoring and Diagnostic Test Market Share (2020-2021)
Table 23. North America NGS-Based Monitoring and Diagnostic Test Market Size by Type (2021-2027) (US$ Million)
Table 24. North America NGS-Based Monitoring and Diagnostic Test Market Share by Type (2021-2027)
Table 25. North America NGS-Based Monitoring and Diagnostic Test Market Size by Application (2021-2027) (US$ Million)
Table 26. North America NGS-Based Monitoring and Diagnostic Test Market Share by Application (2021-2027)
Table 27. Europe Key Players NGS-Based Monitoring and Diagnostic Test Revenue (2020-2021) (US$ Million)
Table 28. Europe Key Players NGS-Based Monitoring and Diagnostic Test Market Share (2020-2021)
Table 29. Europe NGS-Based Monitoring and Diagnostic Test Market Size by Type (2021-2027) (US$ Million)
Table 30. Europe NGS-Based Monitoring and Diagnostic Test Market Share by Type (2021-2027)
Table 31. Europe NGS-Based Monitoring and Diagnostic Test Market Size by Application (2021-2027) (US$ Million)
Table 32. Europe NGS-Based Monitoring and Diagnostic Test Market Share by Application (2021-2027)
Table 33. Japan Key Players NGS-Based Monitoring and Diagnostic Test Revenue (2020-2021) (US$ Million)
Table 34. Japan Key Players NGS-Based Monitoring and Diagnostic Test Market Share (2020-2021)
Table 35. Japan NGS-Based Monitoring and Diagnostic Test Market Size by Type (2021-2027) (US$ Million)
Table 36. Japan NGS-Based Monitoring and Diagnostic Test Market Share by Type (2021-2027)
Table 37. Japan NGS-Based Monitoring and Diagnostic Test Market Size by Application (2021-2027) (US$ Million)
Table 38. Japan NGS-Based Monitoring and Diagnostic Test Market Share by Application (2021-2027)
Table 39. Key Players in China
Table 40. Key Players in Southeast Asia
Table 41. Key Players in India
Table 42. Agilent Technologies, Inc. Company Details
Table 43. Agilent Technologies, Inc. Description and Business Overview
Table 44. Agilent Technologies, Inc. NGS-Based Monitoring and Diagnostic Test Product
Table 45. Agilent Technologies, Inc. Revenue in NGS-Based Monitoring and Diagnostic Test Business 2020 and 2021
Table 46. Agilent Technologies, Inc. Recent Development
Table 47. Ancestry.com LLC Company Details
Table 48. Ancestry.com LLC Description and Business Overview
Table 49. Ancestry.com LLC NGS-Based Monitoring and Diagnostic Test Product
Table 50. Ancestry.com LLC Revenue in NGS-Based Monitoring and Diagnostic Test Business 2020 and 2021
Table 51. Ancestry.com LLC Recent Development
Table 52. ArcherDX, Inc. Company Details
Table 53. ArcherDX, Inc. Description and Business Overview
Table 54. ArcherDX, Inc. NGS-Based Monitoring and Diagnostic Test Product
Table 55. ArcherDX, Inc. Revenue in NGS-Based Monitoring and Diagnostic Test Business 2020 and 2021
Table 56. ArcherDX, Inc. Recent Development
Table 57. Beijing Genomics Institute (BGI) Company Details
Table 58. Beijing Genomics Institute (BGI) Description and Business Overview
Table 59. Beijing Genomics Institute (BGI) NGS-Based Monitoring and Diagnostic Test Product
Table 60. Beijing Genomics Institute (BGI) Revenue in NGS-Based Monitoring and Diagnostic Test Business 2020 and 2021
Table 61. Beijing Genomics Institute (BGI) Recent Development
Table 62. Cancer Genetics, Inc. Company Details
Table 63. Cancer Genetics, Inc. Description and Business Overview
Table 64. Cancer Genetics, Inc. NGS-Based Monitoring and Diagnostic Test Product
Table 65. Cancer Genetics, Inc. Revenue in NGS-Based Monitoring and Diagnostic Test Business 2020 and 2021
Table 66. Cancer Genetics, Inc. Recent Development
Table 67. CENTOGENE AG Company Details
Table 68. CENTOGENE AG Description and Business Overview
Table 69. CENTOGENE AG NGS-Based Monitoring and Diagnostic Test Product
Table 70. CENTOGENE AG Revenue in NGS-Based Monitoring and Diagnostic Test Business 2020 and 2021
Table 71. CENTOGENE AG Recent Development
Table 72. F. Hoffmann-La Roche Ltd Company Details
Table 73. F. Hoffmann-La Roche Ltd Description and Business Overview
Table 74. F. Hoffmann-La Roche Ltd NGS-Based Monitoring and Diagnostic Test Product
Table 75. F. Hoffmann-La Roche Ltd Revenue in NGS-Based Monitoring and Diagnostic Test Business 2020 and 2021
Table 76. F. Hoffmann-La Roche Ltd Recent Development
Table 77. GenePath Dx Company Details
Table 78. GenePath Dx Description and Business Overview
Table 79. GenePath Dx NGS-Based Monitoring and Diagnostic Test Product
Table 80. GenePath Dx Revenue in NGS-Based Monitoring and Diagnostic Test Business 2020 and 2021
Table 81. GenePath Dx Recent Development
Table 82. Illumina, Inc. Company Details
Table 83. Illumina, Inc. Description and Business Overview
Table 84. Illumina, Inc. NGS-Based Monitoring and Diagnostic Test Product
Table 85. Illumina, Inc. Revenue in NGS-Based Monitoring and Diagnostic Test Business 2020 and 2021
Table 86. Illumina, Inc. Recent Development
Table 87. Laboratory Corporation of America Holdings Company Details
Table 88. Laboratory Corporation of America Holdings Description and Business Overview
Table 89. Laboratory Corporation of America Holdings NGS-Based Monitoring and Diagnostic Test Product
Table 90. Laboratory Corporation of America Holdings Revenue in NGS-Based Monitoring and Diagnostic Test Business 2020 and 2021
Table 91. Laboratory Corporation of America Holdings Recent Development
Table 92. Myriad Genetics, Inc. Company Details
Table 93. Myriad Genetics, Inc. Description and Business Overview
Table 94. Myriad Genetics, Inc. NGS-Based Monitoring and Diagnostic Test Product
Table 95. Myriad Genetics, Inc. Revenue in NGS-Based Monitoring and Diagnostic Test Business 2020 and 2021
Table 96. Myriad Genetics, Inc. Recent Development
Table 97. QIAGEN N.V. Company Details
Table 98. QIAGEN N.V. Description and Business Overview
Table 99. QIAGEN N.V. NGS-Based Monitoring and Diagnostic Test Product
Table 100. QIAGEN N.V. Revenue in NGS-Based Monitoring and Diagnostic Test Business 2020 and 2021
Table 101. QIAGEN N.V. Recent Development
Table 102. Quest Diagnostics Incorporated Company Details
Table 103. Quest Diagnostics Incorporated Description and Business Overview
Table 104. Quest Diagnostics Incorporated NGS-Based Monitoring and Diagnostic Test Product
Table 105. Quest Diagnostics Incorporated Revenue in NGS-Based Monitoring and Diagnostic Test Business 2020 and 2021
Table 106. Quest Diagnostics Incorporated Recent Development
Table 107. Siemens Healthineers, Inc. Company Details
Table 108. Siemens Healthineers, Inc. Description and Business Overview
Table 109. Siemens Healthineers, Inc. NGS-Based Monitoring and Diagnostic Test Product
Table 110. Siemens Healthineers, Inc. Revenue in NGS-Based Monitoring and Diagnostic Test Business 2020 and 2021
Table 111. Siemens Healthineers, Inc. Recent Development
Table 112. Thermo Fisher Scientific Inc. Company Details
Table 113. Thermo Fisher Scientific Inc. Description and Business Overview
Table 114. Thermo Fisher Scientific Inc. NGS-Based Monitoring and Diagnostic Test Product
Table 115. Thermo Fisher Scientific Inc. Revenue in NGS-Based Monitoring and Diagnostic Test Business 2020 and 2021
Table 116. Thermo Fisher Scientific Inc. Recent Development
Table 117. HTG Molecular Diagnostics, Inc. Company Details
Table 118. HTG Molecular Diagnostics, Inc. Description and Business Overview
Table 119. HTG Molecular Diagnostics, Inc. NGS-Based Monitoring and Diagnostic Test Product
Table 120. HTG Molecular Diagnostics, Inc. Revenue in NGS-Based Monitoring and Diagnostic Test Business 2020 and 2021
Table 121. HTG Molecular Diagnostics, Inc. Recent Development
Table 122. Vela Diagnostics Pte. Ltd. Company Details
Table 123. Vela Diagnostics Pte. Ltd. Description and Business Overview
Table 124. Vela Diagnostics Pte. Ltd. NGS-Based Monitoring and Diagnostic Test Product
Table 125. Vela Diagnostics Pte. Ltd. Revenue in NGS-Based Monitoring and Diagnostic Test Business 2020 and 2021
Table 126. Vela Diagnostics Pte. Ltd. Recent Development
Table 127. NGS-Based Monitoring and Diagnostic Test Market Trends
Table 128. NGS-Based Monitoring and Diagnostic Test Market Drivers
Table 129. NGS-Based Monitoring and Diagnostic Test Market Challenges
Table 130. NGS-Based Monitoring and Diagnostic Test Market Restraints
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
List of Figures
Figure 1. Global NGS-Based Monitoring and Diagnostic Test Market Share by Type in 2021 & 2027
Figure 2. Commercial Assays/Tests Features
Figure 3. Laboratory Developed Tests Features
Figure 4. Direct to Consumer Test Features
Figure 5. Pre-Commercial Tests Features
Figure 6. Global NGS-Based Monitoring and Diagnostic Test Market Share by Application in 2021 & 2027
Figure 7. Out-Patient Clinics/General Practitioners Case Studies
Figure 8. Diagnostic Centers Case Studies
Figure 9. Hospitals Case Studies
Figure 10. Others Case Studies
Figure 11. NGS-Based Monitoring and Diagnostic Test Report Years Considered
Figure 12. Global NGS-Based Monitoring and Diagnostic Test Market Size and Growth Rate (2020-2027) (US$ Million)
Figure 13. Global NGS-Based Monitoring and Diagnostic Test Market Share by Regions (2020-2027)
Figure 14. Global NGS-Based Monitoring and Diagnostic Test Market Share by Players in 2021
Figure 15. Global NGS-Based Monitoring and Diagnostic Test Market Size Market Share by Type (2021-2027)
Figure 16. Global NGS-Based Monitoring and Diagnostic Test Market Size Market Share by Application (2021-2027)
Figure 17. Global NGS-Based Monitoring and Diagnostic Test Revenue Market Share by Application in 2021
Figure 18. North America NGS-Based Monitoring and Diagnostic Test Market Size 2021-2027 (US$ Million)
Figure 19. Europe NGS-Based Monitoring and Diagnostic Test Market Size 2021-2027 (US$ Million)
Figure 20. Japan NGS-Based Monitoring and Diagnostic Test Market Size 2021-2027 (US$ Million)
Figure 21. NGS-Based Monitoring and Diagnostic Test Market Size in China (2021-2027) (US$ Million)
Figure 22. NGS-Based Monitoring and Diagnostic Test Market Size in Southeast Asia (2021-2027) (US$ Million)
Figure 23. NGS-Based Monitoring and Diagnostic Test Market Size in India (2021-2027) (US$ Million)
Figure 24. Bottom-up and Top-down Approaches for This Report
Figure 25. Data Triangulation
Figure 26. Key Executives Interviewed
世界の糞便免疫化学的診断検査市場規模・現状・予測（2021年-2027年） In a fecal immunochemical diagnostic test, antibodies are used to detect blood in the stool, which bind to a blood protein called hemoglobin found in red blood cells (RBC). A positive result of a fecal immunochemical diagnostic test may be a sign of colorectal cancer, polyps, ulcers or hemorrhoids. …- 世界の嚢胞性線維症診断検査市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Cystic Fibrosis Diagnostic Tests Market The global Cystic Fibrosis Diagnostic Tests market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data…
- 世界のB型肝炎診断検査市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Hepatitis B Diagnostic Tests Market The global Hepatitis B Diagnostic Tests market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integri…
- 世界の肝炎ウイルス診断検査市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Hepatitis Viruses Diagnostic Tests Market The global Hepatitis Viruses Diagnostic Tests market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high …
- 世界のペット診断検査市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Pets Diagnostic Tests Market The global Pets Diagnostic Tests market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report…